Evidence map›Paper›PMID 34072753›Full record

ReviewInternational journal of molecular sciences2021

The Role of NLRP1, NLRP3, and AIM2 Inflammasomes in Psoriasis: Review.

Magdalena Ciążyńska, Irmina Olejniczak-Staruch, Dorota Sobolewska-Sztychny, Joanna Narbutt, Małgorzata Skibińska, Aleksandra Lesiak

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 1 pooled it
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 1 synthesis or guideline pooled it, 82 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Keratinocytes: pleiotropic orchestrators of cutaneous immunity and Inflammation - Emerging therapeutic paradigms in dermatological pathologies.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Magdalena CiążyńskaNicolaus Copernicus Multidisciplinary Centre for Oncology and Traumatology, Department of Proliferative Diseases, 93-513 Lodz, Poland.ORCID 0000-0002-9709-3383
Irmina Olejniczak-StaruchDepartment of Dermatology, Pediatric Dermatology and Dermatological Oncology, Medical University of Lodz, 91-347 Lodz, Poland.
Dorota Sobolewska-SztychnyDepartment of Dermatology, Pediatric Dermatology and Dermatological Oncology, Medical University of Lodz, 91-347 Lodz, Poland.
Joanna NarbuttDepartment of Dermatology, Pediatric Dermatology and Dermatological Oncology, Medical University of Lodz, 91-347 Lodz, Poland.
Małgorzata SkibińskaDepartment of Dermatology, Pediatric Dermatology and Dermatological Oncology, Medical University of Lodz, 91-347 Lodz, Poland.
Aleksandra LesiakDepartment of Dermatology, Pediatric Dermatology and Dermatological Oncology, Medical University of Lodz, 91-347 Lodz, Poland.
Medical University of Lodz · PLCopernicus Memorial Hospital · PL

Funding

National Centre of Science 2017/27/B/NZ5/02011Uniwersytet Medyczny w Lodzi 503/5-064-01/503-1
6 · The paper itself

Abstract

Inflammasomes are high-molecular-weight protein complexes that may cleave the two main proinflammatory cytokines, pro-interleukin-1β and pro-interleukin-18, into active forms, and contribute to psoriasis. Despite recent advances made in the pathogenesis of psoriasis, mainly studied as an autoimmune condition, activation of immune response triggers of psoriasis is still not completely understood. Recently, focus was placed on the role of inflammasomes in the pathogenesis of psoriasis. Multiple types of inhibitors and activators of various inflammasomes, inflammasome-related genes, and genetic susceptibility loci were recognized in psoriasis. In this systemic review, we collect recent and comprehensive evidence from the inflammasomes, NLRP1, NLRP3, and AIM2, in pathogenesis of psoriasis.

Indexed as

Disease SusceptibilityAnimalsBiomarkersDNA-Binding ProteinsHumansInflammasomesMolecular Targeted TherapyNLR Family, Pyrin Domain-Containing 3 ProteinNLR ProteinsProtein BindingPsoriasisSignal TransductionAIM2 protein, humanBiomarkersDNA-Binding ProteinsInflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinNLRP1 protein, humanNLRP3 protein, humanNLR ProteinsAIM2inflammasomesNLRP1NLRP3pathogenesispsoriasis

Identifiers

PMID34072753
PMCPMC8198493
OpenAlexW3165260849

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.